296 related articles for article (PubMed ID: 21901092)
1. The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development.
van der Geize R; Grommen AW; Hessels GI; Jacobs AA; Dijkhuizen L
PLoS Pathog; 2011 Aug; 7(8):e1002181. PubMed ID: 21901092
[TBL] [Abstract][Full Text] [Related]
2. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103+.
Pei Y; Nicholson V; Woods K; Prescott JF
Vet Microbiol; 2007 Nov; 125(1-2):100-10. PubMed ID: 17560744
[TBL] [Abstract][Full Text] [Related]
3. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
4. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
5. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
Kahn SK; Cywes-Bentley C; Blodgett GP; Canaday NM; Turner-Garcia CE; Vinacur M; Cortez-Ramirez SC; Sutter PJ; Meyer SC; Bordin AI; Vlock DR; Pier GB; Cohen ND
PLoS One; 2021; 16(8):e0250133. PubMed ID: 34437551
[TBL] [Abstract][Full Text] [Related]
6. Development of a live, attenuated, potential vaccine strain of R. equi expressing vapA and the virR operon, and virulence assessment in the mouse.
Whitehead AE; Parreira VR; Hewson J; Watson JL; Prescott JF
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):479-84. PubMed ID: 22088674
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a live-attenuated auxotrophic candidate vaccine against the intracellular pathogen Rhodococcus equi.
Lopez AM; Townsend HG; Allen AL; Hondalus MK
Vaccine; 2008 Feb; 26(7):998-1009. PubMed ID: 18055071
[TBL] [Abstract][Full Text] [Related]
8. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
[TBL] [Abstract][Full Text] [Related]
10. Serum Antibody Activity against Poly-
Cohen ND; Kahn SK; Cywes-Bentley C; Ramirez-Cortez S; Schuckert AE; Vinacur M; Bordin AI; Pier GB
Microbiol Spectr; 2021 Sep; 9(1):e0063821. PubMed ID: 34319137
[TBL] [Abstract][Full Text] [Related]
11. Current understanding of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia.
Dawson TRMY; Horohov DW; Meijer WG; Muscatello G
Vet Immunol Immunopathol; 2010 May; 135(1-2):1-11. PubMed ID: 20064668
[TBL] [Abstract][Full Text] [Related]
12. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection.
Chaffin MK; Cohen ND; Martens RJ; Edwards RF; Nevill M; Smith R
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):33-48. PubMed ID: 15182994
[TBL] [Abstract][Full Text] [Related]
13. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
[TBL] [Abstract][Full Text] [Related]
14. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
Prescott JF; Fernandez AS; Nicholson VM; Patterson MC; Yager JA; Viel L; Perkins G
Equine Vet J; 1996 Sep; 28(5):344-9. PubMed ID: 8894530
[TBL] [Abstract][Full Text] [Related]
15. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals.
Caston SS; McClure SR; Martens RJ; Chaffin MK; Miles KG; Griffith RW; Cohen ND
Vet Ther; 2006; 7(4):361-75. PubMed ID: 17216591
[TBL] [Abstract][Full Text] [Related]
16. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
Vanniasinkam T; Barton MD; Heuzenroeder MW
Int J Med Microbiol; 2005 Jan; 294(7):437-45. PubMed ID: 15715172
[TBL] [Abstract][Full Text] [Related]
17. Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.
Lohmann KL; Lopez AM; Manning ST; Marques FJ; Brownlie R; Allen AL; Sangster AE; Mutwiri G; Gerdts V; Potter A; Townsend HG
Can J Vet Res; 2013 Jul; 77(3):161-9. PubMed ID: 24101791
[TBL] [Abstract][Full Text] [Related]
18. Rhodococcus equi pneumonia in the foal--part 1: pathogenesis and epidemiology.
Muscatello G
Vet J; 2012 Apr; 192(1):20-6. PubMed ID: 22015138
[TBL] [Abstract][Full Text] [Related]
19.
Sanz MG; Bradway DS; Horohov DW; Baszler TV
Vet Rec; 2019 Jul; 185(1):19. PubMed ID: 30995996
[No Abstract] [Full Text] [Related]
20. Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development.
Giles C; Vanniasinkam T; Ndi S; Barton MD
Equine Vet J; 2015 Sep; 47(5):510-8. PubMed ID: 24945608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
